- Home
- Science
- Life Sciences
- Signaling Mechanisms of Oxygen and Nitrogen Free Radicals
Signaling Mechanisms of Oxygen and Nitrogen Free Radicals
List Price:
$89.99
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Igor B. Afanas'ev
Format:
Paperback
Pages:
220
Publisher:
CRC Press (September 5, 2019)
Language:
English
Audience:
Professional and scholarly
ISBN-13:
9780367385569
Weight:
16oz
Dimensions:
6.125" x 9.1875"
File:
TAYLORFRANCIS-TayFran_260403050946149-20260403.xml
Folder:
TAYLORFRANCIS
List Price:
$89.99
Country of Origin:
United States
Case Pack:
1
As low as:
$85.49
Publisher Identifier:
P-CRC
Discount Code:
H
Pub Discount:
30
Imprint:
CRC Press
Overview
Exploring major questions regarding signaling mechanisms of reactive oxygen and nitrogen species (ROS/RNS) in enzymatic processes, this volume investigates free radical signaling processes catalyzed by enzymes and examines those producers of superoxide and nitric oxide that use ROS/RNS as signaling species to initiate the process. It considers ROS/RNS sufficiency of signaling production by mitochondrial enzymes, key findings in mitochondrial disorders and subsequent apoptosis, and the development of new treatment potentials for age-related afflictions such as inflammation, cancer, and cardiovascular disease.
